- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02877017
Family Activation and Communication About Errors and Safety (FACES) (FACES)
August 9, 2022 updated by: Alisa Khan, Boston Children's Hospital
Miscommunications are a leading cause of serious medical errors in hospitals, contributing to more than 60% of sentinel events, the most serious adverse events reported to the Joint Commission.
Efforts to improve patient safety in hospitals have centered on improving communication between providers.
While provider-focused communication interventions have led to reductions in patient harm, patients and families have been notably absent from most interventions to improve patient safety.
This proposal seeks to develop a family safety reporting intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
985
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary caregiver of a child hospitalized on the study units during the study period or hospital employee who works on the study unit(s)
- Country of Origin: United States
- Primarily English- or Spanish-speaking
Exclusion Criteria:
- International patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Pre-intervention arm
This arm is the pre-intervention arm of parents and providers before the family safety reporting bundle has been implemented.
|
|
Experimental: Post-intervention arm
This arm is the post-intervention arm of parents and providers after the family safety reporting bundle has been implemented on the study units.
|
family safety reporting intervention for families and providers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
family safety reporting rates
Time Frame: 12 months
|
12 months
|
experience with safety reporting
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
hospital safety culture scores
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alisa Khan, MD, MPH, Boston Children's Hospital/Harvard Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 5, 2018
Primary Completion (Actual)
March 31, 2022
Study Completion (Actual)
March 31, 2022
Study Registration Dates
First Submitted
August 17, 2016
First Submitted That Met QC Criteria
August 19, 2016
First Posted (Estimate)
August 24, 2016
Study Record Updates
Last Update Posted (Actual)
August 11, 2022
Last Update Submitted That Met QC Criteria
August 9, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- IRB-P00022336
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Family Reported Errors and Adverse Events
-
Boston Children's HospitalAgency for Healthcare Research and Quality (AHRQ); Pediatric Research in Inpatient...RecruitingQuality Improvement | Patient Safety | Family Reported Errors and Adverse Events | Health Disparities | Family Safety Reporting | Voluntary Incident ReportingUnited States
-
Institute for Clinical Effectiveness and Health...Ministry of Public Health, Argentina; Hospital JP GarrahanCompletedMedical Errors | Preventable Adverse EventsArgentina
-
Massachusetts General HospitalCompletedPerioperative Medication Errors | Perioperative Adverse Medication EventsUnited States
-
Karen C. Nanji,M.D.,M.P.H.UnknownPerioperative Medication Errors | Perioperative Adverse Medication Events
-
Zhong WangShanxi Zhendong Pharmacy Co., LtdRecruitingAdverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse ReactionsChina
-
Zhong WangShanxi Zhendong pharmaceutical Co. LTD.CompletedAdverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse ReactionsChina
-
AstraZenecaCompletedMajor Adverse Cardiovascular and Cerebrovascular Events (MACCE)Russian Federation
-
Dorothy BreenUniversity of Ulster; Health Research Board, Ireland; Cork University Hospital; Health Service Executive, Ireland and other collaboratorsRecruitingAdverse EventsIreland
-
Copenhagen University Hospital at HerlevCompletedRenal Adverse Events - Contrast Induced Nephropathy (CIN) | Non-renal Adverse EventsDenmark
Clinical Trials on Family safety reporting intervention
-
Boston Children's HospitalAgency for Healthcare Research and Quality (AHRQ); Pediatric Research in Inpatient...RecruitingQuality Improvement | Patient Safety | Family Reported Errors and Adverse Events | Health Disparities | Family Safety Reporting | Voluntary Incident ReportingUnited States
-
Boston Medical CenterCenter for the Study of Social PolicyCompletedChild Abuse | Parenting | Child Development | Child Rearing | Child NeglectUnited States
-
University of MichiganCompletedHigh Risk Population of Part-time Seatbelt Users
-
Oregon Center for Applied Science, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Johns Hopkins Bloomberg School of Public HealthCompletedObesity | Childhood Obesity | Dietary Habits | Water; Lack of | Feeding Behavior | Mother-Child RelationsUnited States
-
University of California, Los AngelesPatient-Centered Outcomes Research Institute; Brown University; Duke University; University of Utah and other collaboratorsRecruiting
-
Boston University Charles River CampusUniversity of Michigan; University of Colorado, Boulder; Denver Health and Hospital... and other collaboratorsRecruiting
-
Seattle Children's HospitalCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteUniversity of South FloridaCompleted
-
Ersta Sköndal University CollegeCompleted